Loading organizations...

§ Venture Capital · Tel Aviv, Israel
early-stage venture capital firm investing in Seed and Series A Israeli startups, providing high-touch support to build global companies.
Aleph VC is an early-stage venture capital firm based in Tel Aviv, Israel, that invests primarily in Seed and Series A technology startups led by Israeli entrepreneurs. The firm manages over $850 million in assets under management across four primary venture funds, generating revenue through management fees and carried interest on its equity investments. In December 2021, the organization successfully closed its fourth fund, Aleph IV, securing $300 million in capital to back emerging technology companies. Its active investment portfolio consists of more than 50 companies operating across the financial technology, enterprise software, consumer technology, logistics, and healthcare sectors. The firm has backed several prominent global brands and public entities, including notable early-stage investments in Lemonade, Melio, HoneyBook, Freightos, and Healthy.io. Aleph VC was officially founded in 2013 by partners Michael Eisenberg and Eden Shochat.
Key people at Aleph VC.
Key people at Aleph VC.
Aleph VC is an early-stage venture capital firm that partners with Israeli entrepreneurs to build impactful global brands. Their mission centers on providing not only capital but also high-touch support to help startups scale internationally. Aleph invests across diverse sectors including real estate tech, cloud computing, e-commerce, fintech, healthcare, and more, focusing on companies that have the potential to become category leaders. The firm plays a significant role in the Israeli startup ecosystem by nurturing companies from seed and Series A stages, helping them grow into meaningful, large-scale businesses with global reach[1][2][3].
Aleph was founded in 2013 and is based in Tel Aviv, Israel. The firm was established by key partners with deep experience in entrepreneurship and venture capital, aiming to fill a gap in early-stage funding combined with operational support for Israeli startups. Over time, Aleph has evolved to become a leading VC in Israel, managing over $850 million in assets and investing in more than 119 companies. Their focus has expanded to include a broad range of innovative sectors while maintaining a strong commitment to partnering closely with founders to build enduring companies[1][2][5].
Aleph rides the wave of Israel’s reputation as the “Startup Nation,” leveraging the country’s strong tech talent and innovation culture. The timing is favorable due to increasing global interest in Israeli technology and the growing demand for digital transformation across industries. Market forces such as the rise of AI, fintech, and cloud computing align well with Aleph’s investment sectors. By supporting early-stage companies with global ambitions, Aleph influences the broader ecosystem by helping Israeli startups become internationally competitive and impactful, thus reinforcing Israel’s position on the global tech map[1][2][3].
Looking ahead, Aleph is poised to continue expanding its portfolio with a focus on emerging technologies and sectors that address global challenges. Trends like AI integration, digital healthcare, and fintech innovation will likely shape their investment strategy. Aleph’s influence is expected to grow as it helps more Israeli startups scale globally, potentially increasing its role as a bridge between Israeli innovation and international markets. Their founder-centric, high-touch model positions them well to adapt to evolving market dynamics and maintain leadership in early-stage venture capital[1][2][5].
Aleph VC has more than 26 tracked investments across 23 companies. The latest tracked deal is $320.0M Series D in Kriya Therapeutics in August 2025.